Edenbridge Pharmaceuticals Selects PANTHERx Rare and Orsini Specialty Pharmacy to Distribute Yargesa to Treat Gaucher Disease
WAINUA™ for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis is available at Orsini Specialty Pharmacy
Takeda Pharmaceuticals Selects Specialty Pharmacy Partners for new FDA-approved drugs ADZYNMA and FRUZAQLA
The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends
The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry
The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry.
The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities
Investment positions Orsini Specialty Pharmacy for continued expansion of patient access and support services across therapies for highly complex and rare diseases